Which mutual funds hold Procter & Gamble Health Limited?

19 mutual funds hold Procter & Gamble Health Limited as of Jul 2026. The highest weight is 4.54% held by UTI - MNC Fund - Growth Option - Direct. Data from official AMFI monthly portfolio disclosures.

What sector is Procter & Gamble Health Limited in?

Procter & Gamble Health Limited is in the Pharmaceuticals & Biotechnology sector and is categorised as by SEBI.

What is the SEBI market cap category of Procter & Gamble Health Limited?

As per SEBI and AMFI classification (Jan-Jun 2026), Procter & Gamble Health Limited is a Small Cap stock ranked #585 with an average market cap of ₹8.92 K Cr.

Pharmaceuticals & Biotechnology

Procter & Gamble Health Limited

ISIN: INE199A01012 · Data as of Jul 2026

Share: WhatsApp ✕ X

Search another stock:

Active Funds Holding

vs Last Month

0 funds

Total Value

₹945.77 Cr

Avg Weight

2.18%

New Entries

Exits

Top Holder

UTI - MNC Fund - Growth Option - Direct 4.54%

ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.

Small Cap Rank #585

₹7.84 K Cr

Avg Mkt Cap · Jan-Jun 2023 (3yr ago)

→

₹8.92 K Cr

Avg Mkt Cap · Jan-Jun 2026 (latest)

+13.8%

3yr change

SEBI · AMFI Market Cap List

📋 What Changed This Month Procter & Gamble Health Limited is currently held by 19 active mutual funds with total exposure of ₹945.77 Cr. This month 3 funds entered and 3 funds exited. UTI - MNC Fund - Growth Option - Direct has the highest allocation at 4.54%. ↓ Scroll down for full fund list and monthly changes.

Trend

How Has Fund Coverage Changed — Last 5 Months?

Month	Funds	AUM (Cr)	AMCs	Status
Jul 2026 REFERENCE	19	₹946	49 / 49	✅ Complete
Jun 2026	19	₹946	49 / 49	✅ Complete
May 2026	20	₹949	49 / 49	✅ Complete
Apr 2026	20	₹832	49 / 49	✅ Complete
Mar 2026	16	₹813	48 / 49

📌 Portfolio changes below are based on Jul 2026 data — the most complete month with 49 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Jul 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

▲ New Entries (3)

ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND 2.16%

WhiteOak Capital Pharma and Healthcare Fund 1.7%

BAJAJ FINSERV SMALL CAP FUND - DIRECT - GROWTH 0.72%

▼ Exits (3)

Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth 2.2%

WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 1.31%

ICICI Prudential Smallcap Fund - Direct Plan - Growth 0.57%

↑ Increased (14)

Sundaram Long Term Tax Advantage Fund Series IV Direct Plan - Growth +0.13%

Sundaram Long Term Tax Advantage Fund Series III Direct Plan - Growth +0.12%

Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth +0.15%

Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct Plan - Growth +0.13%

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth +0.14%

Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct Plan - Growth +0.13%

DSP Healthcare Fund - Direct Plan - Growth +0.03%

Tata India Pharma & Healthcare Fund-Direct Plan-Growth +0.63%

↓ Decreased (2)

UTI - MNC Fund - Growth Option - Direct -0.46%

UTI Healthcare Fund - Direct Plan - Growth Option -0.01%

By Category

Which Fund Categories Hold This Stock?

Category	Funds	Avg Weight
Equity	16	2.48%
Small Cap	2	0.65%
Balanced Advantage	1	0.33%

All Holdings

Which 19 Active Funds Hold Procter & Gamble Health Limited?

Filter:

Fund ↕	Category ↕	Weight ↕	Value ↕	Change ↕
UTI - MNC Fund - Growth Option - Direct UTI Mutual Fund	Equity	4.54%	₹125.40 Cr	-0.46%
Sundaram Long Term Tax Advantage Fund Series IV Direct Plan - Growth Sundaram Mutual Fund	Equity	3.52%	₹81.76 L	+0.13%
Sundaram Long Term Tax Advantage Fund Series III Direct Plan - Growth Sundaram Mutual Fund	Equity	3.29%	₹1.15 Cr	+0.12%
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth Sundaram Mutual Fund	Equity	3.28%	₹1.21 Cr	+0.15%
Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct Plan - Growth Sundaram Mutual Fund	Equity	3.28%	₹1.04 Cr	+0.13%
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth Sundaram Mutual Fund	Equity	3.1%	₹2.41 Cr	+0.14%
Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct Plan - Growth Sundaram Mutual Fund	Equity	3.03%	₹1.13 Cr	+0.13%
DSP Healthcare Fund - Direct Plan - Growth DSP Mutual Fund	Equity	2.9%	₹105.20 Cr	+0.03%
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Tata Mutual Fund	Equity	2.42%	₹37.25 Cr	+0.63%
UTI Healthcare Fund - Direct Plan - Growth Option UTI Mutual Fund	Equity	2.41%	₹33.02 Cr	-0.01%
ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND Aditya Birla Sun Life Mutual Fund	Equity	2.16%	₹23.24 Cr	NEW
Aditya Birla Sun Life MNC Fund - Growth - Direct Plan Aditya Birla Sun Life Mutual Fund	Equity	1.9%	₹62.56 Cr	+0.05%
WhiteOak Capital Pharma and Healthcare Fund WhiteOak Capital Mutual Fund	Equity	1.7%	₹13.99 Cr	NEW
Aditya Birla Sun Life Business Cycle Fund-Direct Growth Aditya Birla Sun Life Mutual Fund	Equity	1.05%	₹18.74 Cr	+0.02%
BAJAJ FINSERV SMALL CAP FUND - DIRECT - GROWTH Bajaj Finserv Mutual Fund	Small Cap	0.72%	₹17.03 Cr	NEW
Baroda BNP Paribas Health and Wellness Fund Direct Growth Baroda BNP Paribas Mutual Fund	Equity	0.64%	₹3.30 Cr	+0.07%
Nippon India Small Cap Fund - Direct Plan Growth Plan - Growth Option Nippon India Mutual Fund	Small Cap	0.58%	₹458.79 Cr	+0.02%
Aditya Birla Sun Life Consumption Fund - Growth - Direct Plan Aditya Birla Sun Life Mutual Fund	Equity	0.48%	₹29.39 Cr	+0.01%
UTI Balanced Advantage Fund - Direct Plan - Growth Option UTI Mutual Fund	Balanced Advantage	0.33%	₹10.09 Cr	+0.01%

Explore More

← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.